Clinical trials

Why choose Queensland for your clinical trials?

We are an extremely attractive location to undertake clinical trials.

Our robust regulatory and tax environment, plus access to world-class researchers and clinicians, creates an ideal market for prototyping, testing, conducting clinical trials, and manufacturing. With modern translational facilities and fast, pragmatic regulatory pathways, our infrastructure is a commercially focused platform for growth.

By choosing Queensland, you can increase the speed of your product R&D. Including southern hemisphere sites means you can access all-year-round recruitment of patients suffering from seasonal ailments, including influenza and allergies, as well as those diagnosed with respiratory and tropical diseases.

Each year, Queensland conducts thousands of clinical trials across hundreds of sites around the state. In 2022–2023 alone, there were more than 320 new clinical trials conducted in Queensland Health, which is the largest provider of clinical trials in the state.

Queensland is also leading the country with its teletrial capability. Teletrial is a proven model that uses telecommunication technology to connect clinical trial clusters to improve access to and participation in clinical trials for regional, rural, and remote Australians.

Further, Queensland is internationally recognised for its highly trained clinical workforce and the high-quality research data produced by its experienced research teams. The state hosts a variety of contract research organisations, health economics, financial and legal services, imaging facilities, genomic services, laboratory services, Good Manufacturing Practice (GMP) manufacturers, and regulatory consultants.

Queensland is part of a nationwide approach which has embraced a fast and pragmatic regulatory pathway for conducting clinical trials. The regulatory framework allows rapid clinical trials start-up through streamlined processes under the Clinical Trials Notification (CTN) scheme administered by the Therapeutic Goods Administration (TGA).

Australian clinical trial data is accepted by international regulatory agencies including the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

As you can see, Queensland is in an ideal position to continue to attract international companies and to build sovereign capability in a number of areas including the development, manufacture, and delivery of vaccines.

There has never been a better time to make the decision to come to Queensland!